4 Recruiting DLBCL Phase 2 Clinical Trials

Active phase 2 studies for dlbcl enrolling across the USA. Verify eligibility and contact site coordinators.

All DLBCL studies

Phase 2 Studies for DLBCL

🔵 Active, Not Recruiting Phase2

A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL

📍 University of Rochester — Rochester, New York

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

📍 Arizona Mayo Clinic — Phoenix, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase2

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

📍 University of Rochester — Rochester, New York

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

📍 Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) — Glendale, Arizona

View Study & Checklist ➔